(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

BESREMI

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

BESREMI

ST13

US500000090606528

Class

5

Filing

90606528

Registration

6885738

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

26

Latest update

04/03/2025

Trademark type

Combined

Nice classes

5

Filing date

03/26/2021

Registration date

10/25/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/25/2022

Last transaction

04/03/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

08/16/2021

First use in commerce

11/13/2021

Drawing code

3

Owner type

03

Owner location

TAIPEI, TW

Examiner

KEATING, MICHAEL

Law office

L10

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the word "BESREMi" in bold red characters, in which "BESREM" in upper case and "I" in lower case with a design to the left. The design consists of a yellow sphere partially wrapped by light blue and dark blue sections. There is a white luster shown at the upper right of the sphere.

Holders and representatives

Holders

P. C. (pessoa física)

Representatives

Brent E. Routman MERCHANT & GOULD P.C.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparationsantineoplastic and immunomodulating agents; pharmaceutical preparations for the treatment of viral infectionscancerspolycythemia vera (PV) and other myeloproliferative neoplasms (MPNs); medicines for human purposes for treating viral infectionscancersPV and other MPNs; chemical-pharmaceutical preparationsfor treating viral infectionscancersPV and other MPNs

Publications

History of USPTO decisions and trademark events.

26 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

10/25/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

10/25/2022

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

09/20/2022

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

09/19/2022

SUPC

STATEMENT OF USE PROCESSING COMPLETE

09/17/2022

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

09/17/2022

IUAF

USE AMENDMENT FILED

09/02/2022

EISU

TEAS STATEMENT OF USE RECEIVED

09/02/2022

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

05/17/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/22/2022

PUBO

PUBLISHED FOR OPPOSITION

03/22/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/02/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/17/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/16/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/15/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/15/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

11/08/2021

GNRT

NON-FINAL ACTION E-MAILED

11/08/2021

CNRT

NON-FINAL ACTION WRITTEN

11/08/2021

DOCK

ASSIGNED TO EXAMINER

11/03/2021

AMPX

PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED

07/17/2021

ALIE

ASSIGNED TO LIE

07/16/2021

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

07/03/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/02/2021

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

05/21/2021

NWAP

NEW APPLICATION ENTERED

03/30/2021

Continuous trademark protection

Get notified about every new filing that threatens BESREMI or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.